Ligand Pharmaceuticals Incorporated (LGND) 2.49 -0.02

Trade LGND
NOW!
Last Trade:1.68Short Ratio:9.80
Last Trade Time:4:00pmDay Range:1.66 - 1.72
Ask:2.49Year Range:1.55 - 3.21
Bid:One Year Target:5.00
Open:1.71Exchange:NGM
Volume:388857EBITDA:-12.4M
Prev. Close:1.70Market Cap:190.5M
50 Day Moving:1.7322Div Yield:
200 day moving:2.0271PE:

SmarTrend's Trend Spotter Sees Continued Downward Momentum on Shares of Ligand Pharmaceuticals (LGND)

Posted on 03/11/10 at 8:27pm
SmarTrend identified a Downtrend for Ligand Pharmaceuticals (NASDAQ: LGND) on December 17, 2009 at $1.85. In approximately 3 months, Ligand Pharmaceuticals has returned 9.2% as of Thursday's closing price of $1.68.
Click here to read the rest of the article

Ligand Pharmaceuticals: The Trend Continues Lower (LGND)

Posted on 03/03/10 at 2:21pm
SmarTrend identified a Downtrend for Ligand Pharmaceuticals (NASDAQ: LGND) on December 17, 2009 at $1.85. In approximately 3 months, Ligand Pharmaceuticals has returned 4.4% as of today's recent price of $1.77.
Click here to read the rest of the article

Ligand to Present at the Cowen & Company 30th Annual Healthcare Conference on March 11

Posted on 03/01/10 at 1:36pm
SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that President and Chief Executive Officer John L. Higgins, and Vice President of Discovery Research Dr.
Click here to read the rest of the article

Ligand Pharmaceuticals: The Trend Continues Down (LGND)

Posted on 02/23/10 at 2:48pm
SmarTrend identified a Downtrend for Ligand Pharmaceuticals (NASDAQ: LGND) on December 17, 2009 at $1.85. In approximately 2 months, Ligand Pharmaceuticals has returned 5.9% as of today's recent price of $1.74.
Click here to read the rest of the article

Ligand Pharmaceuticals: The Trend Continues Lower (LGND)

Posted on 02/10/10 at 6:25pm
SmarTrend identified a Downtrend for Ligand Pharmaceuticals (NASDAQ: LGND) on December 17, 2009 at $1.85. In approximately 2 months, Ligand Pharmaceuticals has returned 13% as of today's recent price of $1.61.
Click here to read the rest of the article

Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Results

Posted on 02/09/10 at 8:20am
SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced financial results for the three and 12 months ended December 31, 2009, and reviewed business highlights of the fourth quarter of 2009 and early 2010.
Click here to read the rest of the article

Ligand Pharmaceuticals Downward Momentum Looks to Continue (LGND)

Posted on 02/03/10 at 5:46am
SmarTrend identified a Downtrend for Ligand Pharmaceuticals (NASDAQ: LGND) on December 17, 2009 at $1.85. In approximately 2 months, Ligand Pharmaceuticals has returned 4.3% as of today's recent price of $1.77.
Click here to read the rest of the article

Ligand to Report Fourth Quarter Results on February 9th

Posted on 02/02/10 at 11:50am
SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that its President and Chief Executive Officer, John L.
Click here to read the rest of the article

Ligand Completes Acquisition of Metabasis

Posted on 01/28/10 at 9:16am
SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that it has completed the acquisition of Metabasis Therapeutics, Inc.
Click here to read the rest of the article